Indications and uses
first aid for the temporary relief of pain and to help protect against infection in minor cuts, scrapes and burns.
first aid for the temporary relief of pain and to help protect against infection in minor cuts, scrapes and burns.
Adults and children 2 years of age and older: Clean the affected area. Dry thoroughly. Brush a small amount of product on the area 1 to 3 times daily and let dry. Hold knees, elbows, knuckles in bent position during application and drying. For more protection, apply second coat. Children under 2 years of age: Consult a doctor.
To remove: peel off or apply a fresh layer of product over dry product and using gauze, rub off gently while still wet. Cap bottle tightly Store at room temperature 15°-25°C (59°-77°F). Keep carton for full drug facts.
Drug Facts
| Active ingredients | Purpose |
|---|---|
| Benzethonium chloride 0.2% | First aid antiseptic |
| Dyclonine hydrochloride 0.75% | Topical analgesic |
first aid for the temporary relief of pain and to help protect against infection in minor cuts, scrapes and burns.
For external use only
Flammable: Keep away from fire or flame
Do not use in the eyes or apply over large areas of the body. In case of deep or puncture wounds, animal bites or serious burns, consult a doctor. Do not use for longer than 1 week unless directed by a doctor.
When using this product avoid contact with the eyes.
Stop use and ask a doctor if the condition gets worse, or if symptoms persist for more than 7 days, or clear up and occur again within a few days.
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Adults and children 2 years of age and older:
Children under 2 years of age:
acetone, amyl acetate, castor oil, drometrizole, ethyl acetate, nitrocellulose, SD alcohol 40-B
call 1-800-344-7239
Distributed by: Insight Pharmaceuticals Corp.
Langhorne, PA 19047-1749
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1048366 | benzethonium Cl 0.2 % / dyclonine HCl 0.75 % Topical Solution | PSN | 1 |
| 1053196 | Skin Shield 0.2 % / 0.75 % Topical Solution | PSN | 1 |
| 1053196 | benzethonium chloride 2 MG/ML / dyclonine hydrochloride 7.5 MG/ML Topical Solution [Skin Shield] | SBD | 1 |
| 1048366 | benzethonium chloride 2 MG/ML / dyclonine hydrochloride 7.5 MG/ML Topical Solution | SCD | 1 |
| 1048366 | benzethonium Cl 0.2 % / dyclonine HCl 0.75 % Topical Solution | SY | 1 |
| 1053196 | Skin Shield (benzethonium Cl 0.2 % / dyclonine HCl 0.75 % ) Liquid Bandage | SY | 1 |
| 1053196 | Skin Shield (benzethonium Cl 0.2 % / dyclonine HCl 0.75 % ) Topical Solution | SY | 1 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 1da7d10e-498b-41dd-970f-0f5bd7432f39 | Product name | 1 | 20190228 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63736-293-24 | 2019-10-21 | C162847 | 48780-1 | 956f9ecf-c441-621f-e053-dbdaa90a74ad | Skin Shield ® Liquid Bandage |
| 63736-293-36 | 2019-10-21 | C162847 | 48780-1 | 956f9ecf-c441-621f-e053-dbdaa90a74ad | Skin Shield ® Liquid Bandage |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63736-293-24 | Skin Shield | 24 in 1 CASE | LIQUID | 24 | 1 | |
| 63736-293-24 | Skin Shield | 1 in 1 BOX | LIQUID | 1 | 1 | |
| 63736-293-36 | Skin Shield | 36 in 1 CASE | LIQUID | 36 | 1 | |
| 63736-293-36 | Skin Shield | 1 in 1 BOX | LIQUID | 1 | 1 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Benzethonium Chloride | ACTIVE INGREDIENT | PH41D05744 | 1 | |
| Dyclonine Hydrochloride | ACTIVE INGREDIENT | ZEC193879Q | 1 | |
| Benzethonium | ACTIVE MOIETY | 1VU15B70BP | 1 | |
| Dyclonine | ACTIVE MOIETY | 078A24Q30O | 1 | |
| Acetone | INACTIVE INGREDIENT | 1364PS73AF | 1 | |
| Amyl Acetate | INACTIVE INGREDIENT | 92Q24NH7AS | 1 | |
| Castor Oil | INACTIVE INGREDIENT | D5340Y2I9G | 1 | |
| Drometrizole | INACTIVE INGREDIENT | 5X93W9OFZL | 1 | |
| Ethyl Acetate | INACTIVE INGREDIENT | 76845O8NMZ | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 63736-293 | 63736-293-24, 63736-293-36 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Benzethonium Chloride | PH41D05744 | ACTIB |
| Dyclonine Hydrochloride | ZEC193879Q | ACTIB |
| Acetone | 1364PS73AF | IACT |
| Amyl Acetate | 92Q24NH7AS | IACT |
| Castor Oil | D5340Y2I9G | IACT |
| Drometrizole | 5X93W9OFZL | IACT |
| Ethyl Acetate | 76845O8NMZ | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Castor Oil | CASTOR OIL | D5340Y2I9G | SOLUTION / TOPICAL | 1.38 %w/w | ||
| Castor Oil | CASTOR OIL | D5340Y2I9G | TABLET / SUBLINGUAL | 1.6 mg | ||
| Ethyl Acetate | ETHYL ACETATE | 76845O8NMZ | SOLUTION / TOPICAL | 31 %w/w | ||
| Ethyl Acetate | ETHYL ACETATE | 76845O8NMZ | SOLUTION / ORAL | 13 mg | ||
| Castor Oil | CASTOR OIL | D5340Y2I9G | CAPSULE / ORAL | 1.04 mg | ||
| Acetone | ACETONE | 1364PS73AF | TABLET, EXTENDED RELEASE / ORAL | NA | ||
| Castor Oil | CASTOR OIL | D5340Y2I9G | INJECTION, SOLUTION / INTRAMUSCULAR | 525 mg | ||
| Castor Oil | CASTOR OIL | D5340Y2I9G | TABLET / ORAL | 17 mg | ||
| Castor Oil | CASTOR OIL | D5340Y2I9G | EMULSION / OPHTHALMIC | 32 mg | ||
| Castor Oil | CASTOR OIL | D5340Y2I9G | TABLET, DELAYED RELEASE / ORAL | 0.01 mg | ||
| Castor Oil | CASTOR OIL | D5340Y2I9G | SPRAY / NASAL | NA | ||
| Castor Oil | CASTOR OIL | D5340Y2I9G | TABLET, EXTENDED RELEASE / ORAL | 23.27 mg | ||
| Ethyl Acetate | ETHYL ACETATE | 76845O8NMZ | SYSTEM / TRANSDERMAL | 41 mg | ||
| Ethyl Acetate | ETHYL ACETATE | 76845O8NMZ | SUSPENSION / ORAL | NA | ||
| Castor Oil | CASTOR OIL | D5340Y2I9G | TABLET, COATED / ORAL | 0.9 mg | ||
| Ethyl Acetate | ETHYL ACETATE | 76845O8NMZ | TABLET, EXTENDED RELEASE / ORAL | NA | ||
| Castor Oil | CASTOR OIL | D5340Y2I9G | OINTMENT / TOPICAL | 14.9 %w/w | ||
| Castor Oil | CASTOR OIL | D5340Y2I9G | GRANULE, FOR SUSPENSION / ORAL | 128 mg | ||
| Castor Oil | CASTOR OIL | D5340Y2I9G | GEL / NASAL | 429 mg | ||
| Castor Oil | CASTOR OIL | D5340Y2I9G | INJECTION / INTRAMUSCULAR | 885 mg | ||
| Ethyl Acetate | ETHYL ACETATE | 76845O8NMZ | CAPSULE, EXTENDED RELEASE / ORAL | 382.26 mg | ||
| Ethyl Acetate | ETHYL ACETATE | 76845O8NMZ | FILM, EXTENDED RELEASE / TRANSDERMAL | 0.05 mg | ||
| Castor Oil | CASTOR OIL | D5340Y2I9G | TABLET, FILM COATED / ORAL | 15.29 mg | ||
| Castor Oil | CASTOR OIL | D5340Y2I9G | CAPSULE, EXTENDED RELEASE / ORAL | 47 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 6265bf84-0828-494b-b781-55351012e3e4 | bc596cfe-1229-42c1-940b-c40a81ead64f | 2010-06-22 | Warnings | 6265bf84-0828-494b-b781-55351012e3e4 bc596cfe-1229-42c1-940b-c40a81ead64f |
Adverse event summaries are temporarily unavailable. Other product information remains available.